A Gateway between Omics Data and Systems Biology
Journal Title: Journal of Metabolomics & Systems Biology - Year 2013, Vol 1, Issue 1
Abstract
Metabolomics captures the cellular chemistry and thereby the ultimate realization of numerous genetic, transcriptional, and enzymatic events. The mechanistic interpretation of small molecules as substrates, intermediates, or products of biochemical action is necessary to place metabolites into the correct physiological context of a system. Therefore, the tight connection between omics technologies and systems biology is vital.
Authors and Affiliations
Fabian V. Filipp
Keywords
Related Articles
- EP ID EP246879
- DOI 10.13188/2329-1583.1000003
- Views 103
- Downloads 0
A Gateway between Omics Data and Systems Biology
Metabolomics captures the cellular chemistry and thereby the ultimate realization of numerous genetic, transcriptional, and enzymatic events. The mechanistic interpretation of small molecules as substrates, intermediates...
Extraction of Molecular Features through Exome to Transcriptome Alignment
Integrative Next Generation Sequencing (NGS) DNA and RNA analyses have very recently become feasible, and the published to date studies have discovered critical disease implicated pathways, and diagnostic and therapeutic...
Emerging Applications of Metabolomics in Drug Development
Background: Metabolomics has been increasingly applied in biomedical research and drug efficacy evaluation in the context of rapid advances in analytical instrumentation and bioinformatics. Metabolomics-based discovery w...
Metabolomics: How it can be applied in Infectious Medicine?
Bioinformatics becomes a very useful scientific technology at present. It can be applied in several purposes including to medicine. In medicine, the well-known genomics and proteomics have been widely applied in diagnost...
Efficacy and Toxicity Assessment of Different Clinically Used Small Molecular Tyrosine Kinase Inhibitors by Computational Molecular Docking Method
Along with the antibody based antiangiogenic (AAG) drugs, several small molecular antiangiogenic (sAAG) drugs are also in clinical practice for the treatment of different cancers. Though population based clinical trials...